Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Precision Biosciences (DTIL) Equity Ratio (2018 - 2025)

Precision Biosciences (DTIL) has disclosed Equity Ratio for 8 consecutive years, with 0.6 as the latest value for Q4 2025.

  • Quarterly Equity Ratio rose 44.48% to 0.6 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.6 through Dec 2025, up 44.48% year-over-year, with the annual reading at 0.6 for FY2025, 44.48% up from the prior year.
  • Equity Ratio for Q4 2025 was 0.6 at Precision Biosciences, up from 0.18 in the prior quarter.
  • The five-year high for Equity Ratio was 0.6 in Q4 2025, with the low at 0.12 in Q4 2023.
  • Average Equity Ratio over 5 years is 0.32, with a median of 0.33 recorded in 2022.
  • The sharpest move saw Equity Ratio plummeted 58.24% in 2021, then soared 250.28% in 2024.
  • Over 5 years, Equity Ratio stood at 0.43 in 2021, then crashed by 41.14% to 0.25 in 2022, then tumbled by 53.48% to 0.12 in 2023, then skyrocketed by 250.28% to 0.41 in 2024, then surged by 44.48% to 0.6 in 2025.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 0.6, 0.18, and 0.31 for Q4 2025, Q3 2025, and Q2 2025 respectively.